HLA-G as a prognostic marker in stage II/III colorectal cancer: not quite there yet
Alessandro Gambella(Ospedale Policlinico San Martino), Luca Mastracci(Ospedale Policlinico San Martino)
Cited by 13
Related Papers
PD-L1 evaluation in the gastrointestinal tract: from biological rationale to its clinical application
|Pathologica|2022|41
Response to ipilimumab therapy in metastatic melanoma patients: potential relevance of CTLA-4+ tumor infiltrating lymphocytes and their in situ localization
|Cancer Immunology Immunotherapy|2020|25
Author Correction: Fasting-mimicking diet and hormone therapy induce breast cancer regression
|Nature|2020|11
Counting mitoses in gastrointestinal stromal tumours (GISTs): variable practices in the real-world setting and their clinical implications
|Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin|2022|6